Basics |
Haemonetics Corporation
Haemonetics Corp is a health care company. It provides products enabling in the processing, handling and analysis of blood and portfolio of integrated devices and information management tools to improve clinical outcomes.
|
IPO Date: |
January 3, 1994 |
Sector: |
Healthcare |
Industry: |
Health Care Equipment and Supplies |
Market Cap: |
$3.58B |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.75 | 1.20%
|
Avg Daily Range (30 D): |
$0.79 | 1.06%
|
Avg Daily Range (90 D): |
$0.80 | 1.21%
|
Institutional Daily Volume |
Avg Daily Volume: |
.3M |
Avg Daily Volume (30 D): |
.44M |
Avg Daily Volume (90 D): |
.47M |
Trade Size |
Avg Trade Size (Sh.): |
85 |
Avg Trade Size (Sh.) (30 D): |
44 |
Avg Trade Size (Sh.) (90 D): |
43 |
Institutional Trades |
Total Inst.Trades: |
8,712 |
Avg Inst. Trade: |
$2.7M |
Avg Inst. Trade (30 D): |
$4.3M |
Avg Inst. Trade (90 D): |
$4.2M |
Avg Inst. Trade Volume: |
.04M |
Avg Inst. Trades (Per Day): |
2 |
Market Closing Trades |
Avg Closing Trade: |
$3.74M |
Avg Closing Trade (30 D): |
$7.26M |
Avg Closing Trade (90 D): |
$7.13M |
Avg Closing Volume: |
52.32K |
|
|
Financials |
|
TTM |
Q4 2025 |
FY 2025 |
Basic EPS
|
$3.33
|
|
$3.33
|
Diluted EPS
|
$3.31
|
|
$3.31
|
Revenue
|
$ 1.36B
|
$
|
$ 1.36B
|
Gross Profit
|
$ 748.96M
|
$
|
$ 748.96M
|
Net Income / Loss
|
$ 167.68M
|
$
|
$ 167.68M
|
Operating Income / Loss
|
$ 221.82M
|
$
|
$ 221.82M
|
Cost of Revenue
|
$ 611.87M
|
$
|
$ 611.87M
|
Net Cash Flow
|
$ 127.96M
|
$
|
$ 127.96M
|
PE Ratio
|
0.00
|
|
|
|
|
|